Elucidation of Immune-Privileged Mechanisms in Human Uterine-Mesenchymal Stem Cells (Ut-Mscs) and in Vivo Validation in Inflammatory Bowel Disease (Ibd)

2021-08-012024-05-18https://scholars.lib.ntu.edu.tw/handle/123456789/707947Elucidation of Immune-Privileged Mechanisms in Human Uterine-Mesenchymal Stem Cells (Ut-Mscs) and in Vivo Validation in Inflammatory Bowel Disease (Ibd)